Stay updated on Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.

Latest updates to the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, signaling an incremental software update; no visible study content changes are indicated.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision updated to v3.6.4, replacing the previous v3.6.3. This indicates an updated build of the study page.SummaryDifference0.0%

- Check35 days agoChange DetectedExplicit definitions for responder rates are added: 50%, 75%, and 100% reductions in PGTC seizures per 28-day interval during the Maintenance Phase, and a 50% reduction for all generalized seizures per 28-day interval, with Baseline and Maintenance Phase time frames and the calculation methods. These additions clarify how efficacy outcomes are measured during the Double-blind Treatment Period and Maintenance Phase.SummaryDifference0.6%

- Check50 days agoChange DetectedThe page's study locations were expanded with many new sites across multiple countries, and new results publication metadata (including posted dates and PDFs) was added; several previously listed locations and outcome-description items were removed.SummaryDifference3%

- Check57 days agoChange DetectedThe page's revision tag was updated to v3.6.2, replacing the previous v3.6.0 revision.SummaryDifference0.0%

- Check71 days agoChange DetectedNew user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a top-level notice states that the study is no longer looking for participants. A formatting change from "Intervention/Treatment" to "Intervention / Treatment" and the new Revision: v3.6.0 (replacing v3.5.5) were also applied.SummaryDifference0.2%

Stay in the know with updates to Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.